Literature DB >> 22306194

Metabolic differences underlying two distinct rat urinary phenotypes, a suggested role for gut microbial metabolism of phenylalanine and a possible connection to autism.

T Andrew Clayton1.   

Abstract

A novel explanation is proposed for the metabolic differences underlying two distinct rat urinary compositional phenotypes i.e. that these may arise from differences in the gut microbially-mediated metabolism of phenylalanine. As part of this hypothesis, it is further suggested that elements of the mammalian gut microbiota may convert phenylalanine to cinnamic acid, either by means of an ammonia lyase-type reaction or by means of a three step route via phenylpyruvate and phenyllactate. The wider significance of such conversions is discussed with similar metabolism of tryptophan and subsequent glycine conjugation potentially explaining the origin of trans-indolylacryloylglycine, a postulated marker for autism.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22306194     DOI: 10.1016/j.febslet.2012.01.049

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

1.  Does the human gut microbiota contribute to the etiology of autism spectrum disorders?

Authors:  Petra Louis
Journal:  Dig Dis Sci       Date:  2012-08       Impact factor: 3.199

2.  Microbial-Derived Metabolites Reflect an Altered Intestinal Microbiota during Catch-Up Growth in Undernourished Neonatal Mice.

Authors:  Geoffrey A Preidis; Nadim J Ajami; Matthew C Wong; Brooke C Bessard; Margaret E Conner; Joseph F Petrosino
Journal:  J Nutr       Date:  2016-04-06       Impact factor: 4.798

3.  NMR-Based Metabolomics of Rat Hippocampus, Serum, and Urine in Two Models of Autism.

Authors:  B Toczylowska; E Zieminska; R Polowy; K H Olszynski; J W Lazarewicz
Journal:  Mol Neurobiol       Date:  2022-06-17       Impact factor: 5.682

Review 4.  Microbiome and metabolome data integration provides insight into health and disease.

Authors:  Michael Shaffer; Abigail J S Armstrong; Vanessa V Phelan; Nichole Reisdorph; Catherine A Lozupone
Journal:  Transl Res       Date:  2017-07-14       Impact factor: 7.012

Review 5.  Does our gut microbiome predict cardiovascular risk? A review of the evidence from metabolomics.

Authors:  Julian L Griffin; Xinzhu Wang; Elizabeth Stanley
Journal:  Circ Cardiovasc Genet       Date:  2015-02

6.  Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome.

Authors:  Richard E Frye; Shannon Rose; John Slattery; Derrick F MacFabe
Journal:  Microb Ecol Health Dis       Date:  2015-05-07

7.  The gut: a triggering place for autism - possibilities and challenges.

Authors:  Tore Midtvedt
Journal:  Microb Ecol Health Dis       Date:  2012-08-24

8.  Gluten- and casein-free dietary intervention for autism spectrum conditions.

Authors:  Paul Whiteley; Paul Shattock; Ann-Mari Knivsberg; Anders Seim; Karl L Reichelt; Lynda Todd; Kevin Carr; Malcolm Hooper
Journal:  Front Hum Neurosci       Date:  2013-01-04       Impact factor: 3.169

Review 9.  Environment, dysbiosis, immunity and sex-specific susceptibility: a translational hypothesis for regressive autism pathogenesis.

Authors:  Alessandra Mezzelani; Martina Landini; Francesco Facchiano; Maria Elisabetta Raggi; Laura Villa; Massimo Molteni; Barbara De Santis; Carlo Brera; Anna Maria Caroli; Luciano Milanesi; Anna Marabotti
Journal:  Nutr Neurosci       Date:  2014-01-21       Impact factor: 4.994

Review 10.  Increased glutamate and homocysteine and decreased glutamine levels in autism: a review and strategies for future studies of amino acids in autism.

Authors:  Ahmad Ghanizadeh
Journal:  Dis Markers       Date:  2013-09-12       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.